Diagnostics, Specialty Care Fuel ₹10,000 Cr+ Healthcare Deals in Q2 FY26: EY

From a valuation perspective, healthcare assets continued to command premium multiples, with EV/EBITDA multiples for leading listed players ranging from the mid-teens to over 30x, reflecting confidence in long-term demand and consolidation-led growth.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/fAojQlm
via